2012
DOI: 10.1007/s00259-012-2166-0
|View full text |Cite
|
Sign up to set email alerts
|

Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases

Abstract: SAM is a promising parameter for tumour response assessment of liver metastases by means of (18)F-fluorodeoxyglucose PET.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
30
0
1

Year Published

2012
2012
2016
2016

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 23 publications
(31 citation statements)
references
References 27 publications
0
30
0
1
Order By: Relevance
“…5. Standardized added metabolic activity (SAM) [23]. This figure-of-merit was defined as follows: a first VOI (VOI1) was drawn around the lesion and a second VOI (VOI2) was delineated.…”
Section: Tumour Uptake and Volumetric Parametersmentioning
confidence: 99%
“…5. Standardized added metabolic activity (SAM) [23]. This figure-of-merit was defined as follows: a first VOI (VOI1) was drawn around the lesion and a second VOI (VOI2) was delineated.…”
Section: Tumour Uptake and Volumetric Parametersmentioning
confidence: 99%
“…However, there is growing interest in using alternative measurements, for instance metabolically active tumour volume (MATV) and heterogeneity metrics, in order to provide a more comprehensive quantitative assessment of lesions from PET images [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…For all these reasons, a novel parameter, called standardized added metabolic (SAM) activity recently proposed by Mertens and colleagues [16] in the European Journal of Nuclear Medicine and Molecular Imaging, may be of particular interest. The attractiveness of this parameter is its potential independence from an accurate MATV determination as well as PVE.…”
mentioning
confidence: 99%
“…A preliminary clinical evaluation of this new PET imagederived parameter was performed as part of the same study [16] considering 19 patients with colorectal carcinoma undergoing baseline and treatment follow-up PET scans (after three to six chemotherapy cycles). In this patient population, consisting of only responders and nonresponders, no statistically significant differences were found between SUV max and SAM for assessing response to therapy based on PET imaging.…”
mentioning
confidence: 99%